Express News | Perspective Therapeutics Inc : Jonestrading Adjusts Target Price to $21 From $2.2 to Reflect 1-for-10 Reverse Stock Split

ReutersJun 18 23:27 ET

JonesTrading Maintains Perspective Therapeutics(CATX.US) With Buy Rating, Cuts Target Price to $21

JonesTrading analyst Justin Walsh maintains $Perspective Therapeutics(CATX.US)$ with a buy rating, and adjusts the target price from $22 to $21.According to TipRanks data, the analyst has a success ra

moomoo NewsJun 18 13:32 ET · Ratings

Express News | Refile-Perspective Therapeutics : Oppenheimer Adjusts Target Price to $19 From $2 to Reflect 1-for-10 Reverse Stock Split (Clarifies PT Is Split-Adjusted)

ReutersJun 18 10:13 ET

Express News | Cantor Fitzgerald Reiterates Overweight on Perspective Therapeutics

BenzingaJun 18 10:00 ET

Perspective Therapeutics(CATX.US) Officer Buys US$17,667 in Common Stock

$Perspective Therapeutics(CATX.US)$ Officer Hunt Jonathan Robert purchased 1,800 shares of common stock on Jun 17, 2024 at an average price of $9.815 for a total value of $17,667.Source: Announcement

moomoo NewsJun 18 08:31 ET

Oppenheimer Maintains Perspective Therapeutics(CATX.US) With Buy Rating, Cuts Target Price to $19

Oppenheimer analyst Jeff Jones maintains $Perspective Therapeutics(CATX.US)$ with a buy rating, and adjusts the target price from $20 to $19.According to TipRanks data, the analyst has a success rate

moomoo NewsJun 18 08:31 ET · Ratings